|
|
Volumn 105, Issue 5, 2005, Pages 1841-1842
|
|
"T"-ing off on nasopharynx cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELL NUCLEUS ANTIGEN;
LATENT MEMBRANE PROTEIN 1;
LATENT MEMBRANE PROTEIN 2;
NUCLEAR PROTEIN;
T LYMPHOCYTE RECEPTOR;
ADOPTIVE IMMUNOTHERAPY;
CYTOTOXIC T LYMPHOCYTE;
DRUG EFFICACY;
EPSTEIN BARR VIRUS;
GENE EXPRESSION;
IN VITRO STUDY;
LYMPHOPROLIFERATIVE DISEASE;
NASOPHARYNX CANCER;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TUMOR CELL;
CULTURE TECHNIQUE;
HUMAN;
IMMUNOLOGY;
METHODOLOGY;
NASOPHARYNX TUMOR;
NOTE;
TRANSPLANTATION;
TREATMENT OUTCOME;
VIROLOGY;
CELL CULTURE TECHNIQUES;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
NASOPHARYNGEAL NEOPLASMS;
T-CELL ANTIGEN RECEPTOR SPECIFICITY;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
|
EID: 14944339113
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2004-12-4770 Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
